» Articles » PMID: 29196090

Diagnostic Performance of Stress Perfusion Cardiac Magnetic Resonance for the Detection of Coronary Artery Disease: A Systematic Review and Meta-analysis

Overview
Journal Int J Cardiol
Publisher Elsevier
Date 2017 Dec 3
PMID 29196090
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The purpose of this study was to investigate the accuracy of qualitative stress perfusion cardiac magnetic resonance (CMR) to diagnose ischemia-causing lesions according to different definitions of significant coronary artery disease (CAD), and magnetic field strength.

Methods: We searched PubMed, Web of Science, and the Cochrane Library for studies evaluating diagnostic performance of qualitative stress perfusion CMR for diagnosis of CAD versus coronary angiography or fractional flow reserve (FFR) from inception to 10 September 2017. We used hierarchical models to synthesize the available data.

Results: Sixty-seven studies (7113 patients) met the inclusion criteria. The patient-based analysis of studies using FFR as the reference standard demonstrated a mean sensitivity of 0.90 (95% confidence interval [CI], 0.85-0.93) and a mean specificity of 0.85 (95% CI, 0.80-0.89). The patient-based analyses for detecting coronary stenosis ≥50% and coronary stenosis ≥70% at 1.5T and for detecting coronary stenosis ≥50% and coronary stenosis ≥70%, at 3T, demonstrated a mean sensitivity of 0.82 (95% CI, 0.79-0.84), 0.86 (95% CI, 0.83-0.89), 0.90 (95% CI, 0.82-0.95), and 0.91 (95% CI, 0.79-0.96), respectively; with a mean specificity of 0.75 (95% CI, 0.71-0.80), 0.77 (95% CI, 0.71-0.81), 0.79 (95% CI, 0.69-0.86), and 0.74 (95% CI, 0.59-0.85).

Conclusion: Qualitative stress perfusion CMR has high accuracy for the diagnosis of CAD, irrespective of the reference standard and the magnet strength. Studies using FFR as the reference standard had higher diagnostic accuracy on a patient level compared to studies using coronary angiography, with a notable difference in specificity.

Citing Articles

[Utility of Cardiac Magnetic Resonance with Pharmacological Stress to assess Myocardial Ischemia].

Ramirez S, Paucca E Arch Peru Cardiol Cir Cardiovasc. 2024; 1(1):15-23.

PMID: 38571971 PMC: 10986348. DOI: 10.47487/apcyccv.v1i1.8.


The Value of a Coronary Computed Tomography Angiography plus Stress Cardiac Magnetic Resonance Imaging Strategy for the Evaluation of Patients with Chronic Coronary Syndrome.

Busi G, Amico M, Vannini M, Virgili G, Migliorini A, Pontecorboli G J Clin Med. 2024; 13(6).

PMID: 38541780 PMC: 10971722. DOI: 10.3390/jcm13061556.


Assessment of the Efficiency of Non-Invasive Diagnostic Imaging Modalities for Detecting Myocardial Ischemia in Patients Suspected of Having Stable Angina.

Iwata K, Ogasawara K Healthcare (Basel). 2023; 11(1).

PMID: 36611483 PMC: 9818638. DOI: 10.3390/healthcare11010023.


Cardiovascular Magnetic Resonance Parametric Mapping Techniques for the Assessment of Chronic Coronary Syndromes.

Bazmpani M, Nikolaidou C, Papanastasiou C, Ziakas A, Karamitsos T J Cardiovasc Dev Dis. 2022; 9(12).

PMID: 36547440 PMC: 9782163. DOI: 10.3390/jcdd9120443.


Stress Perfusion Cardiac Magnetic Resonance Imaging With a 3.0-Tesla Scanner for Myocardial Viability in a Patient With a Conditional Pacemaker.

Motazedian P, Prosperi-Porta G, Ahmed M, Hafeez M, Merchant N, Heydari B CJC Open. 2022; 4(6):581-584.

PMID: 35734513 PMC: 9207775. DOI: 10.1016/j.cjco.2022.02.009.